These include an IL-2 ELISPOT assay using recombinant M. tb antigen (secreted L-alanine dehydrogenase [AlaDH]) that distinguished active TB and LTBI in a prospective study with a sensitivity of 100% and specificity of 81% [35]. This evidence concerns the gene ALAD and tuberculosis.